Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive

Similar documents
Innovation & health connected. Business plan summary

Empowering young people. headspace Strategic Plan

NHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY

Helping your business grow in the UK health system

NHS Next Stage Review: Innovation

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver

Digital Health Strategy

Industrial Strategy Green Paper Response from The Institute of Cancer Research, London

Cultural Evolution Is the future in our own hands?

NIHR ROADSHOW FOR MEDTECH SMES

ABHI Response to the Kennedy short study on Valuing Innovation

the royal society of new zealand: gateway to science and technology strategic priorities

Corporate slide master

Medicines Manufacturing in the UK 2017

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018

Human factors and design in future health care

Security and Risk Assessment in GDPR: from policy to implementation

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

A Science & Innovation Audit for the West Midlands

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

THE NUMBERS OPENING SEPTEMBER BE PART OF IT

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

South Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only

CCG 360 o stakeholder survey 2017/18

Portsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Collaboration Agreement

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

Sutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Diffusion of Innovations Theory. 2 nd National Medicine Reconciliation Workshop - 6 September 2011

Health & Social Care Industrial Innovation

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017

Draft Plan of Action Chair's Text Status 3 May 2008

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

FDA Centers of Excellence in Regulatory and Information Sciences

Technology transfer options for low-carbon development

IFT STRATEGIC PLAN. 2017/18 Strategic Objectives

We are embarking on a new and exciting phase of dance development in the North West. This is where we get to dream big.

Health Innovation Manchester

[Definitions of terms that are underlined are found at the end of this document.]

Catapult Network. Launching your ideas with the UK s new centres for innovation

Enfield CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

Sutton CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

Growing the national institute for data science and artificial intelligence

Technology and Innovation in the NHS Highlands and Islands Enterprise

Board of Directors Non Executive Directors

Smart Management for Smart Cities. How to induce strategy building and implementation

Medical Education Activities

SAFEGUARDING ADULTS FRAMEWORK. Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services.

Centre for Healthcare Technologies

The case for quality

Accountable Officer Report

RESEARCH AND INNOVATION STRATEGY

Quality by Design, Clinical Relevance & Lifecycle Considerations

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only

IAPT What Now? What Next? Kevin Mullins Head of Mental Health 2 nd October 2015

Kernow CCG CCG 360 o Stakeholder Survey

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

The Royal College of Radiologists Response to: House of Lords Select Committee on Artificial Intelligence 6 September 2017

2. Evidence themes and their importance along the development path

Innovation & Knowledge management

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

A review of the role and costs of clinical commissioning groups

Led by clinicians, accountable to local people. East Lancashire Clinical Commissioning Group: Equality & Inclusion Annual Report

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

Imagine your future lab. Designed using Virtual Reality and Computer Simulation

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

WorldSkills UK Construction Roundtable Report: The future of construction is manufacturing June 2018

The Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program

Intellectual Property

June 12, 2017 Health and the Social Innovation Ecosystem

CCG Improvement and Assessment Framework 2016/17. Briefing Document

A Roadmap For Building Indigenous Digital Excellence: Looking To 2030

Parkinson s World A transformational project by The Cure Parkinson s Trust

Before I talk through the strategy itself, I want to tell you more about why

Diversity in Science Technology Engineering and Maths (STEM)

About the awards. Categories. Knowledge Transfer Initiative of the Year Knowledge Transfer Achiever of the Year. Judging panel

NEWS RELEASE. Life sciences companies tout their expertise in India

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund

Triennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence

Supporting Innovation through Regulation and Science

NIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators

Eastern Cheshire CCG CCG 360 o Stakeholder Survey

EU s Innovative Medical Technology and EMA s Measures

WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP?

Mining Innovation: The Importance of Science Entreprise

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

Digital Health and Introducing Innovative Technologies in the NHS

How Paediatric Research Networks can help drug development

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

NHS England CCG Authorisation

INTRODUCTION OUR VISION: We are driven to be a preeminent college of pharmacy in the world. Our world begins in Iowa. OUR MISSION:

Foreword. Simon Hunt Managing Director Oxford Policy Management

DR ANDREA PAVLICKOVA EUROPEAN SERVICE DEVELOPMENT MANAGER NHS 24, SCOTLAND

TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19

Transcription:

Opportunities and Challenges in Pharmaceutical Sciences Helen Gordon Chief Executive

Challenges we face

Drivers for Change in Health Care... and science too Desire for high quality, safe services. The need for cost effectiveness not just efficiencies The need for fast adoption and diffusion of innovation Changing demography, long term conditions time bomb Complexity of therapy New technologies The need for a flexible and adaptable workforce Balancing national and local Focus on outcomes

Cross Sector Change Working in Partnership Challenges Innovations Efficiencies Effectiveness

Changes in Workforce Development LETBs Health Education England Levy and Tariff

All about adopting and spreading innovation Science, health and education working closely together Pharmaceutical science is core Growing the economy through innovation

Quality Innovation Education and Development Effectiveness Delivery

Pharmaceutical Science - meeting the challenges - making the most of opportunities

Pharmaceutical Science - Crucial to Patient Care Formulations Solubility Patency of veins, running more than 1 drug into a line at the same time Managed entry of new drugs Palatability and formulations

Directions of Travel in Healthcare Do elements of this this resonate with you as well? Clinical Leadership and ownership that delivers: Quality improvement Best outcomes for patients Best use of resources Planning and designing integrated care pathways Strategies for service planning, research and health improvement Leadership and engagement Working collaboratively across systems Patient/User involvement, not just engagement

Royal Colleges Role - Support and Influence Professional Support. Professional Development & Advancement Leadership and advocacy Science and Research Professional Recognition Professional Standards

RPS working for Pharmacists and Pharmaceutical Scientists We work with our partners, such as APS, to ensure: SCIENCE is heard and understood, championed and valued Our partner s voices are heard and promoted in the development and delivery of healthcare policy and medicines expertise Their contribution to patient and public health is recognised and acknowledged They are positioned and trusted as the experts in medicines They are recognised as valued partners with the NHS, the science community, UKPLC and wider society. RPS recognition scheme coming soon.

High Media Presence http://www.rpharms.com/about-us/media-centre.asp

In Summary RPS and APS collaborate to: Ensure that pharmaceutical science is recognised as integral to patient care and wellbeing of the public. Spell out where pharmacy and pharmaceutical science add value, and how the professional bodies aid in this process. Create space for leaders to consider innovation and its spread. Ensure pharmaceutical science is embedded in educational change for pharmacists. Support changes to develop flexible and adaptable workforces in industry, healthcare, academia and research. As individuals, we: Make local connections that support advancement and change. Build partnerships at a national and local level will help patient care and business. Be passionate about developments and opportunities.

Thank you

RPS Science Award Presented by Helen Gordon Chief Executive

RPS Science Award Dr Khuloud Al-Jamal, King s College London